About
Northwind Bio develops in vivo gene editing therapies for inherited liver and blood disorders, with two programmes in Phase 1 and a third entering the clinic in 2027.
In good company
Other sponsors
Become a sponsor
Headline, stream and exhibition packages are available for 2027.